Hu, Juanjuan
Ke, Junli
Xu, Shufeng
Pei, Lei
Cao, Lulu
Zhou, Huanhao
Zhu, Xisong
Article History
Received: 5 August 2024
Accepted: 26 November 2024
First Online: 5 December 2024
Declarations
:
: This retrospective study was approved by the Ethics Committee of Quzhou People’s Hospital and the informed consent requirement was waived (No. AF/SW-05/01.0-2023-045).
: Not applicable.
: The authors declare no competing interests.
: AVS, adjacent vessel sign; ALN, axillary lymph node.BES, breast edema score.BPS, breast peritumor score.EDCE, early dynamic contrast-enhanced.ER, estrogen receptor.CPA, clinicopathological-AVS.CPF, clinicopathological-FBE.CPP, clinicopathological-BPS.FBE, focal breast edema.LVI, lymphovascular invasion.M-IDC, mass-type invasive ductal carcinoma.MIP, maximum intensity projection.T1WI, T1-weighted.T2WI, T2-weighted sequence.